RT Journal Article T1 EUS-guided tissue acquisition in the study of the adrenal glands: Results of a nationwide multicenter study. A1 Martin-Cardona, A A1 Fernandez-Esparrach, G A1 Subtil, J C A1 Iglesias-Garcia, J A1 Garcia-Guix, M A1 Barturen Barroso, A A1 Gimeno-Garcia, A Z A1 Esteban, J M A1 Pardo Balteiro, A A1 Velasco-Guardado, A A1 Vazquez-Sequeiros, E A1 Loras, C A1 Martinez-Moreno, B A1 Castellot, A A1 Huertas, C A1 Martinez-Lapiedra, M A1 Sanchez-Yague, A A1 Teran, A A1 Morales-Alvarado, V J A1 Betes, M A1 de la Iglesia, D A1 Sánchez-Montes, C A1 Lozano, M D A1 Lariño-Noia, J A1 Gines, A A1 Tebe, C A1 Gornals, J B A1 On belhaf of Spanish Group for EUS-Guided TA in the adrenal gland, AB There are limited data about the role of endoscopic ultrasound-guided tissue acquisition (EUS-TA), by fine needle aspiration (EUS-FNA) or biopsy (EUS-FNB), in the evaluation of the adrenal glands (AG). The primary aim was to assess the diagnostic yield and safety. The secondary aims were the malignancy predictors, and to create a predictive model of malignancy. This was a retrospective nationwide study involving all Spanish hospitals experienced in EUS-TA of AGs. Inclusion period was from April-2003 to April-2016. Inclusion criteria: all consecutive cases that underwent EUS-TA of AGs. EUS and cytopathology findings were evaluated. Statistical analyses: diagnostic accuracy of echoendoscopist's suspicion using cytology by EUS-TA, as gold standard; multivariate logistic regression model to predict tumor malignancy. A total of 204 EUS-TA of AGs were evaluated. Primary tumor locations were lung70%, others19%, and unknown11%. AG samples were adequate for cytological diagnosis in 91%, and confirmed malignancy in 60%. Diagnostic accuracy of the endosonographer's suspicion was 68%. The most common technique was: a 22-G (65%) and cytological needle (75%) with suction-syringe (66%). No serious adverse events were described. The variables most associated with malignancy were size>30mm (OR2.27; 95%CI, 1.16-4.05), heterogeneous echo-pattern (OR2.11; 95%CI, 1.1-3.9), variegated AG shape (OR2.46; 95%CI, 1-6.24), and endosonographer suspicion (OR17.46; 95%CI, 6.2-58.5). The best variables for a predictive multivariate logistic model of malignancy were age, sex, echo-pattern, and AG-shape. EUS-TA of the AGs is a safe, minimally invasive procedure, allowing an excellent diagnostic yield. These results suggest the possibility of developing a pre-EUS procedure predictive malignancy model. YR 2019 FD 2019-06-06 LK https://hdl.handle.net/10668/26717 UL https://hdl.handle.net/10668/26717 LA en DS RISalud RD Apr 5, 2025